Week In Review: Biocytogen, A Genetically Modified Animal Models Company, Stages $60 Million IPO
September 03, 2022 at 16:51 PM EDT
Beijing Biocytogen Pharma completed a $60 million IPO on the Hong Kong Exchange for its genetically modified animal and cell model business, which it offers to pharmaceutical/biotech companies. Biocytogen has a market capitalization of $357 million.
